1. Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis

   • Miao Liu
   • Fei Xie
   • Shu Wang

   Review 09 February 2021 Pages: 591 - 605

   

2. Different strategies in marking axillary lymph nodes in breast cancer patients undergoing neoadjuvant medical treatment: a systematic review

   • Vivian Man
   • Ava Kwong

   Review 21 February 2021 Pages: 607 - 615

   

3. Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy

   • Kate R. Pawloski
   • Audree B. Tadros
   • Laurie J. Kirstein

   Review Open access 06 March 2021 Pages: 617 - 624

   

4. Covid-19 related oncologist’s concerns about breast cancer treatment delays and physician well-being (the CROWN study)

   • Katharine A. Yao
   • Deanna Attai
   • David Victorson

   Preclinical study 31 January 2021 Pages: 625 - 635

   

5. Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration

   • Rupa Guha
   • Binbin Yue
   • Ginette Serrero

   Preclinical study 22 February 2021 Pages: 637 - 653

   

6. Prognostic significance of phosphoglycerate dehydrogenase in breast cancer

   • Muthukrishnan Chandrika
   • Pei Jou Chua
   • Boon Huat Bay

   Preclinical study 24 February 2021 Pages: 655 - 665

   

7. Immunohistochemical HER2 score correlates with response to neoadjuvant chemotherapy in HER2-positive primary breast cancer

   • Yihong Wang
   • Kamaljeet Singh
   • Evgeny Yakirevich

   Preclinical study 17 February 2021 Pages: 667 - 676

   

8. Differential gene expression analysis of palbociclib-resistant TNBC via RNA-seq

   • Lilibeth Lanceta
   • Nadiia Lypova
   • Yoannis Imbert-Fernandez

   Preclinical study Open access 18 February 2021 Pages: 677 - 686

   

9. Biomarkers of response to camrelizumab combined with apatinib: an analysis from a phase II trial in advanced triple-negative breast cancer patients

   • Jieqiong Liu
   • Ying Li
   • Qiang Liu

   Preclinical Study 25 February 2021 Pages: 687 - 697

   

10. Pregnancy-associated breast cancer: nationwide Dutch study confirms a discriminatory aggressive histopathologic profile

    • B. B. M. Suelmann
    • C. van Dooijeweert
    • P. J. van Diest

    Preclinical study Open access 26 February 2021 Pages: 699 - 704

11. Prospective evaluation of sexual health in breast cancer women during the first year of adjuvant hormonal treatment using a cancer patient's dedicated questionnaire: A glaring gap of communication between health professionals and patients

    • Leticia Aptecar
    • Frederic Fiteni
    • Veronique D’Hondt

    Clinical trial 15 January 2021 Pages: 705 - 713

    

12. Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results

    • A. Coolbrandt
    • A. T’Jonck
    • H. Wildiers

    Clinical trial 16 January 2021 Pages: 715 - 722

13. The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgery

    • Gerald Gui
    • Effrosyni Panopoulou
    • Clare M. Isacke

    Clinical trial 04 January 2021 Pages: 723 - 730

14. Comparison of short-term surgical outcomes between men and women with breast cancer: a retrospective study using nationwide inpatient data in Japan

    • Takaaki Konishi
    • Michimasa Fujiogi
    • Hideo Yasunaga

    Clinical trial 05 January 2021 Pages: 731 - 739

15. Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers

    • Sabine Grill
    • Maryam Yahiaoui-Doktor
    • Marion Kiechle

    Clinical trial Open access 04 February 2021 Pages: 741 - 752

    

16. Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer

    • Leonardo Roberto da Silva
    • Camila Annicchino de Andrade
    • Luiz Carlos Zeferino

    Clinical trial 04 February 2021 Pages: 753 - 760

    

17. Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing

    • W. Iris Zhi
    • Raymond E. Baser
    • Ting Bao

    Clinical trial 28 January 2021 Pages: 761 - 768

    

18. Association between lincRNA expression and overall survival for patients with triple-negative breast cancer

    • Jie Ping
    • Shuya Huang
    • Xiao-Ou Shu

    Epidemiology 27 November 2020 Pages: 769 - 777

    

19. Predictive role of HER2-status on the effectiveness of endocrine adjuvant treatment in postmenopausal breast cancer patients: a population-based cohort study

    • Aglaia Schiza
    • Davide Mauri
    • Antonios Valachis

    Epidemiology Open access 30 November 2020 Pages: 779 - 789

    

20. Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II

    • Mia M. Gaudet
    • Emily Deubler
    • Susan M. Gapstur

    Epidemiology 04 January 2021 Pages: 791 - 805

21. Similar rates of residual disease in patients with DCIS within 2 mm of lumpectomy margin regardless of the presence of invasive carcinoma

    • Bridget N. Kelly
    • Olga Kantor
    • Michelle C. Specht

    Epidemiology 28 November 2020 Pages: 807 - 814

    

22. Tumor phenotype and concordance in synchronous bilateral breast cancer in young women

    • Linda M. Pak
    • Rachel Gaither
    • Ann H. Partridge

    Epidemiology 26 November 2020 Pages: 815 - 821

23. Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women

    • Taruna Rajagopal
    • Arun Seshachalam
    • Nageswara Rao Dunna

    Epidemiology 04 January 2021 Pages: 823 - 837

    

24. BRCA testing and outcomes in women with breast cancer

    • David D. Stenehjem
    • Claire Telford
    • Joseph E. Biskupiak

    Epidemiology 03 January 2021 Pages: 839 - 850

    

25. Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?

    • N. I. Bouwer
    • T. G. Steenbruggen
    • A. Jager

    Epidemiology Open access 04 January 2021 Pages: 851 - 862

    

26. Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer

    • M. Moossdorff
    • Marissa L. G. Vane
    • M. L. Smidt

    Epidemiology Open access 10 March 2021 Pages: 863 - 870

    

27. Outcomes of systemic therapy in metastatic phyllodes tumor of the breast

    • Amanda Parkes
    • Wei-Lien Wang
    • Ravin Ratan

    Brief Report 11 February 2021 Pages: 871 - 882

    

28. Letter to the editor

    • Parinita Keshav Swarnkar
    • Kefah Mokbel

    Letter to the Editor 03 March 2021 Pages: 883 - 884

    

29. Activity of novel anti-HER2 agents for breast cancer based on hormone receptors expression

    • Paolo Tarantino
    • Giuseppe Curigliano

    Letter to the Editor 25 February 2021 Pages: 885 - 886

    

30. Octopus anastomosis: selection of anastomotic configuration in lymphaticovenular anastomosis according to vessels’ conditions

    • Tomohiro Kojimahara
    • Takashi Kageyama

    Letter to the Editor 04 March 2021 Pages: 887 - 888